New research found that in most types of breast cancer patients, high levels of CCL5 in plasma promote the expression of CX3CL1 to promote breast cancer cell proliferation through epidermal growth factor signal transduction pathway, and also promote epithelial‐mesenchymal transition.34 This evidence concerns the gene CX3CL1 and breast carcinoma.